Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Sara Saheb Kashaf, Lucy A. Godley, Angad Chadha, Jason B. Waldinger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)119-122
Number of pages4
JournalJAAD Case Reports
Volume37
DOIs
StatePublished - Jul 2023

Funding

Funding sources: None.

Keywords

  • alopecia
  • chronic myeloproliferative neoplasm
  • germline SDHC mutation
  • ripretinib
  • systemic mastocytosis

ASJC Scopus subject areas

  • Dermatology

Cite this